These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34132500)

  • 21. Mulberry fruit ameliorates Parkinson's-disease-related pathology by reducing α-synuclein and ubiquitin levels in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model.
    Gu PS; Moon M; Choi JG; Oh MS
    J Nutr Biochem; 2017 Jan; 39():15-21. PubMed ID: 27741433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
    J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease.
    Prediger RD; Aguiar AS; Moreira EL; Matheus FC; Castro AA; Walz R; De Bem AF; Latini A; Tasca CI; Farina M; Raisman-Vozari R
    Curr Pharm Des; 2011; 17(5):489-507. PubMed ID: 21375482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotective effects of osmotin in Parkinson's disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways.
    Park JS; Choe K; Lee HJ; Park TJ; Kim MO
    J Biomed Sci; 2023 Aug; 30(1):66. PubMed ID: 37568205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating Parkinson's Disease via Activation of BDNF/TrkB Signaling Pathways and Inhibition of Delta-Secretase.
    Kang SS; Wu Z; Liu X; Edgington-Mitchell L; Ye K
    Neurotherapeutics; 2022 Jul; 19(4):1283-1297. PubMed ID: 35595958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feruloylated oligosaccharides ameliorate MPTP-induced neurotoxicity in mice by activating ERK/CREB/BDNF/TrkB signalling pathway.
    Ding Y; Zhou M; Zheng R; Ma R; Deng J; Hao WZ; Wang L; Zhang JC; Ho CT; Huang JQ
    Phytomedicine; 2023 Jan; 108():154512. PubMed ID: 36288652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurogenic effects of rotarod walking exercise in subventricular zone, subgranular zone, and substantia nigra in MPTP-induced Parkinson's disease mice.
    Leem YH; Park JS; Park JE; Kim DY; Kim HS
    Sci Rep; 2022 Jun; 12(1):10544. PubMed ID: 35732806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of ATP production ameliorates motor and cognitive impairments in a mouse model of MPTP-induced Parkinson's disease.
    Haga H; Matsuo K; Yabuki Y; Zhang C; Han F; Fukunaga K
    Neurochem Int; 2019 Oct; 129():104492. PubMed ID: 31229554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic Potential of Repeated Intravenous Transplantation of Human Adipose-Derived Stem Cells in Subchronic MPTP-Induced Parkinson's Disease Mouse Model.
    Park H; Chang KA
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease.
    Pupyshev AB; Tikhonova MA; Akopyan AA; Tenditnik MV; Dubrovina NI; Korolenko TA
    Pharmacol Biochem Behav; 2019 Feb; 177():1-11. PubMed ID: 30582934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress.
    Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ
    Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabidiol Alleviates the Damage to Dopaminergic Neurons in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinson's Disease Mice Via Regulating Neuronal Apoptosis and Neuroinflammation.
    Wang L; Wu X; Yang G; Hu N; Zhao Z; Zhao L; Li S
    Neuroscience; 2022 Aug; 498():64-72. PubMed ID: 35792194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zinc (Zn) and adipose-derived mesenchymal stem cells (AD-MSCs) on MPTP-induced Parkinson's disease model: A comparative evaluation of behavioral and immunohistochemical results.
    Yildirim S; Oylumlu E; Ozkan A; Sinen O; Bulbul M; Goksu ET; Ertosun MG; Tanriover G
    Neurotoxicology; 2023 Jul; 97():1-11. PubMed ID: 37146888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain-derived neurotrophic factor.
    Komnig D; Dagli TC; Habib P; Zeyen T; Schulz JB; Falkenburger BH
    J Neurochem; 2018 Dec; 147(5):678-691. PubMed ID: 30152864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice.
    Ding YX; Xia Y; Jiao XY; Duan L; Yu J; Wang X; Chen LW
    Neurochem Res; 2011 Oct; 36(10):1759-66. PubMed ID: 21562748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silibinin attenuates motor dysfunction in a mouse model of Parkinson's disease by suppression of oxidative stress and neuroinflammation along with promotion of mitophagy.
    Liu X; Liu W; Wang C; Chen Y; Liu P; Hayashi T; Mizuno K; Hattori S; Fujisaki H; Ikejima T
    Physiol Behav; 2021 Oct; 239():113510. PubMed ID: 34181930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice.
    Patil SP; Jain PD; Ghumatkar PJ; Tambe R; Sathaye S
    Neuroscience; 2014 Sep; 277():747-54. PubMed ID: 25108167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral Administration of Silibinin Ameliorates Cognitive Deficits of Parkinson's Disease Mouse Model by Restoring Mitochondrial Disorders in Hippocampus.
    Liu X; Wang C; Liu W; Song S; Fu J; Hayashi T; Mizuno K; Hattori S; Fujisaki H; Ikejima T
    Neurochem Res; 2021 Sep; 46(9):2317-2332. PubMed ID: 34097239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the effect of rotenone and 1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine on inducing chronic Parkinson's disease in mouse models.
    Zhang J; Sun B; Yang J; Chen Z; Li Z; Zhang N; Li H; Shen L
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35039876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective effect of Eugenia uniflora against intranasal MPTP-induced memory impairments in rats: The involvement of pro-BDNF/p75
    Savall ASP; Fidelis EM; de Mello JD; Quines CB; Denardin CC; Marques LS; Klann IP; Nogueira CW; Sampaio TB; Pinton S
    Life Sci; 2023 Jul; 324():121711. PubMed ID: 37088413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.